Clinical Trial Update: Cytomegalovirus Spread and Reactivation in Blood Cells

View source ↗

Summary

A National Heart, Lung, and Blood Institute–funded clinical trial investigating cytomegalovirus spread and reactivation in blood cells has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blood Disorders
• Cytomegalovirus Infections

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Blood Disease, Cytomegalovirus Infections | Status: COMPLETED